Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. April 2026 04:43 ET | Quelle: Research and Markets

Crohn's Disease Eight-Market Drug Forecast and Market Analysis Report 2025-2026: Novel MOAs Will Provide Market Shifts Throughout the Forecast Period to 2032

Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The "Crohn's Disease: Eight-Market Drug Forecast and Market Analysis - Update (2025)" report has been added to ResearchAndMarkets.com's offering.This...
09. April 2026 10:10 ET | Quelle: Research and Markets

UCB S.A. Digital Transformation Strategy Analysis Report 2025: Accelerators, Innovation Programs, Technology Initiatives, ICT, Partnerships, Investments & Acquisitions, Network Map

Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: UCB - 2025" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights...
07. April 2026 07:00 ET | Quelle: Soleo Health Holdings, Inc.

Soleo Health Relocates Denver Specialty Pharmacy to Support Continued Growth

FRISCO, Texas and CENTENNIAL, Colo., April 07, 2026 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the opening...
02. April 2026 11:00 ET | Quelle: Crohn's and Colitis Canada

Le programme de bourses d'études MII d’AbbVie fête ses 15 ans : les candidatures sont ouvertes pour 2026

TORONTO, 02 avr. 2026 (GLOBE NEWSWIRE) -- Crohn et Colite Canada et AbbVie sont heureux d'annoncer l'ouverture des candidatures pour le Programme de bourses d'études MII d’AbbVie 2026. Cette année...
02. April 2026 11:00 ET | Quelle: Crohn's and Colitis Canada

AbbVie IBD Scholarship Program Marks 15 Years: Applications Open for 2026

Crohn’s and Colitis Canada and AbbVie open applications for the 2026 AbbVie IBD Scholarship, marking 15 years of supporting students living with IBD.
13. März 2026 07:53 ET | Quelle: Research and Markets

Zymfentra (Celltrion) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Zymfentra Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
24. Februar 2026 07:03 ET | Quelle: Research and Markets

Inflammatory Bowel Disease Treatment Market Competitive Landscape Report 2025: Top Players Analysis, Profiles, Strategic Developments, Mergers, Product Launches, Sustainability Goals, Revenue Insights

Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Inflammatory Bowel Disease Treatment Market Company Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights,...
20. Februar 2026 08:00 ET | Quelle: AltruBio Inc.

AltruBio Announces Formation of Inflammatory Bowel Disease Clinical Advisory Board

SAN FRANCISCO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company developing novel immune checkpoint enhancers to address the unmet need...
19. Februar 2026 16:02 ET | Quelle: Spyre Therapeutics, Inc.

Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

On track for 6 proof-of-concept readouts in 2026 across the SKYLINE and SKYWAY Phase 2 trials Part A readouts from SKYLINE platform trial in ulcerative colitis ("UC") expected to begin in the second...
18. Februar 2026 10:28 ET | Quelle: Research and Markets

JAK Inhibitors Competitive Landscape Report 2026: Comprehensive Insights on 40+ Companies and 45+ Drugs by Company, Product Type, Development Stage, Administration Route, Molecule Type

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "JAK Inhibitors - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report delivers a detailed analysis of over...

Vorherige Seite